Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.
Saved in:
| Title: | Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. |
|---|---|
| Authors: | Lynce F; Georgetown Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia., Blackburn MJ; Georgetown Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia., Zhuo R; Georgetown University School of Medicine, Georgetown University, Washington, District of Columbia., Gallagher C; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, District of Columbia., Hahn OM; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Abu-Khalaf M; Sidney Kimmel Cancer Center at Jefferson Health, Thomas Jefferson University, Philadelphia, Pennsylvania., Mohebtash M; MedStar Franklin Square Cancer Center, Baltimore, Maryland., Wu T; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University Medical Center, Washington, District of Columbia., Pohlmann PR; Georgetown Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia., Dilawari A; Georgetown Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia.; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, District of Columbia., Tiwari SR; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, District of Columbia., Chitalia A; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, District of Columbia., Warren R; Georgetown Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia., Tan M; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University Medical Center, Washington, District of Columbia., Shajahan-Haq AN; Georgetown University Medical Center and Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia., Isaacs C; Georgetown Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia. |
| Source: | Cancer [Cancer] 2021 Oct 01; Vol. 127 (19), pp. 3622-3630. Date of Electronic Publication: 2021 Jun 22. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0142 |
|---|---|
| DOI: | 10.1002/cncr.33620 |
